Dermatologic

RSS

Silkis licensed to Galderma

April 12, 1996

ADCON-L efficacy reported

April 5, 1996

New 5alpha-reductase inhibitor from Merck & Co.

March 26, 1996

Antipsoriatic treatment in development at Immune Response

March 15, 1996

Human Genome Sciences claims novel wound-healing agents

March 15, 1996